Download PERSPECTIVES ON BACULOVIRUS EXPRESSION SYSTEMS

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

RNA-Seq wikipedia , lookup

Cell culture wikipedia , lookup

Cell-penetrating peptide wikipedia , lookup

Protein moonlighting wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Biochemical cascade wikipedia , lookup

Gene regulatory network wikipedia , lookup

Signal transduction wikipedia , lookup

Two-hybrid screening wikipedia , lookup

Silencer (genetics) wikipedia , lookup

Secreted frizzled-related protein 1 wikipedia , lookup

Gene therapy of the human retina wikipedia , lookup

Gene expression profiling wikipedia , lookup

Gene expression wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Channelrhodopsin wikipedia , lookup

List of types of proteins wikipedia , lookup

Transcript
BACULOVIRUS SUMMARY
Page 1 of 3
PERSPECTIVES ON BACULOVIRUS EXPRESSION SYSTEMS
Dr. Bart Frank, Arthritis and Immunology Program
Overview
In a previous session, advantages of expressing heterologous genes in E. coli were discussed. While
high levels of expression in bacterial systems are common, problems of proper folding and lack of posttranslational processing may produce functionally inactive molecules. The baculovirus expression
system can be used to circumvent these problems.
Baculoviruses infect primarily insects with a narrow host range. Autographa californica, the most
commonly used baculovirus for protein expression, infects only 2 lepidopteran (moth) families in nature.
Although these viruses may enter other cells types (perhaps by phagocytosis), they are not infectious in
them. For example, nucleocapsid proteins are not removed in most human cells. In human hepatic cell
lines that do remove these proteins, the virus fails to replicate and express proteins due to the absence of
insect transcription factors. Thus, working with baculoviruses is considered safe for humans and
contamination of mammalian cell lines in shared biosafety hoods is not a problem. Recombinant DNA
guidelines recommend a BL1 biosafety level for most baculovirus expression experiments.
Advantages and disadvantages of protein expression in baculovirus
There are many advantages to using baculovirus for heterologous gene expression. Heterologous cDNA
is expressed well. Proper transcriptional processing of genes with introns occurs but are expressed less
efficiently. As with other eukaryotic expression systems, baculovirus expression of heterologous genes
permits folding, post-translational modification and oligomerization in manners that are often identical
to those that occur in mammalian cells. The insect cytoplasmic environment allows proper folding and
S-S bond formation, unlike the reducing environment of the E. coli cytoplasm. Post-translational
processing identical to that of mammalian cells has been reported for many proteins. These include
proper proteolysis, N- and O-glycosylation, acylation, amidation, carboxymethylation, phosphorylation,
and prenylation. Proteins may be secreted from cells or targeted to different subcellular locations. Single
polypeptide, dimeric and trimeric proteins have been expressed in baculoviruses. Finally, expression of
heterologous proteins is under the control of the strong polyhedrin promoter, allowing levels of
expression of up to 30% of the total cell protein.
Despite these potential advantages, particular patterns of post-translational processing and expression
must be empirically determined for each construct. Differences in proteins expressed by mammalian and
baculovirus infected insect cells have been described and overcome in some cases. For example,
inefficient secretion from insect cells may be circumvented by the addition of insect secretion signals
(ex. honeybee melittin sequence). Improperly folded proteins and proteins that occur as intracellular
aggregates may be due to expression late in the infection cycle. In such cases, harvesting cells at earlier
times after infection may help. Low levels of expression can often be increased with optimization of
time of expression and multiplicity of infection. The complete analysis of carbohydrate structures has
been reported for a limited number of glycoproteins. Potential N-linked glycosylation sites are often
either fully glycosylated or not glycosylated at all, as opposed to expression of various glycoforms that
may occur in mammalian cells. Species-specific or tissue-specific modifications are unlikely to occur.
Insect Cell Culture
SF-9, SF-21, and High-Five insect cells are commonly used for baculovirus expression. SF-9 and SF-21
are ovarian cell lines from Spodoptera frugiperda. They are grown in Grace's (or a similar) media
supplemented with 10% fetal calf serum, lactalbumin, and yeastolate. High-Five cells are egg cells from
Trichoplusia ni. These cells are less expensive to maintain since they may be grown without fetal calf
http://omrf.ouhsc.edu/~frank/baculsum.html
3/15/2004
BACULOVIRUS SUMMARY
Page 2 of 3
serum. They reportedly express higher levels of recombinant proteins, although we have found these
differences to be minimal. All three cells lines may be grown at room temperature (optimum = 25 - 27°
C), and do not require CO2 incubators. Their doubling time is 18-24 hours.
Generalized Outline for Protein Expression in Baculovirus
Given the variations of proteins to be expressed, no single protocol will satisfy every need. An outline
for baculovirus expression is given below. One should plan 1-2 months to accomplish these goals:
1. Ligate the gene of interest to a bacterial transfer vector. The inserts are typically flanked by
portions of viral genes to permit homologous recombination with replication defective, linear,
viral DNA. Vectors or inserts may include sequences for protein targeting and purification. Verify
direction of the inserts relative to the polyhedrin promoter and purify plasmids for transfections
into insect cells.
2. Co-transfect insect cells with the recombinant transfer vector and a linearized viral vector.
Electroporation, lipid, and calcium phosphate-mediated transformations work well. Replicative
viruses are formed after intracellular homologous recombination between the ends of the viral
molecules and portions of the transfer vector that flank the gene of interest. These recombination
events insert your gene into the virus and complement defective viral gene(s) to permit viral
replication. In some vectors, this may also generate production of marker proteins such as betagalactosidase. Non-recombinant viruses are kept to a minimum with this system.
3. Harvest the transfected cell supernatants.
4. Infect insect cells with dilutions of this supernatant to isolate single virus plaques. Identification of
viral plaques can be difficult without the presence of a marker gene product such as betagalactosidase.
5. Infect additional insect cells with viruses from these plaques to amplify the quantity and titer of
viral stocks. Protein expression in these cells may be examined in Western blots.
6. Optimize the level of protein expression (MOI, time course of infection) and test for activity in an
appropriate bioassay.
Summary
In summary, heterologous gene expression in baculovirus systems offers several advantages over E. coli.
The viruses are considered safe for laboratory personnel. Insect cells infected with the virus recognize
and properly process a variety of recognition signals in mammalian, plant and yeast genes, and provide
moderate to high yields of biologically active proteins for study.
There are numerous books and articles on baculovirus expression. A thorough reference and useful
technical manual on this subject is Baculovirus Expression Vectors by D. R. O'Reilly, L. K. Miller, and
V. A. Luckow (1992, W. H. Freeman & Co, New York). Invitrogen has established an internet
baculovirus discussion group that may be of interest or helpful in troubleshooting. Many companies now
sell baculovirus expression vectors or complete expression systems. We have had personal experience
and success with products from Invitrogen (http://www.invitrogen.com) and Clontech
(http://www.clontech.com/). Detailed procedures from experiments with baculovirus expression in my
laboratory can be found in the protocols section of my web page (http://omrf.ouhsc.edu/~frank).
http://omrf.ouhsc.edu/~frank/baculsum.html
3/15/2004
BACULOVIRUS SUMMARY
Page 3 of 3
Prepared for the November 1998 OMRF Research Technology Forum.
Send comments and updates to Dr. Bart Frank, Arthritis and Immunology Program, OMRF
Return to Baculovirus Protocol Page
http://omrf.ouhsc.edu/~frank/baculsum.html
3/15/2004